Mavyret (glecaprevir/pibrentasvir) is an expensive drug used to treat hepatitis C. It is more popular than comparable drugs. There are currently no generic alternatives for Mavyret. It is not covered by most Medicare and insurance plans, but manufacturer and pharmacy coupons can help offset the cost.

With the Patient Assistance Program from HealthWell Foundation, contact the program to see how they can financially help you out.